メタボリック関連脂肪肝疾患とメタボリック関連脂肪肝疾患のない患者の心血管リスクに対する睡眠時間の差異的影響:国家健康栄養調査とメンデルのランダム化による証拠
関連する実験動画
Updated: Sep 9, 2025

07:33
Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
7.9K
Siyao Wang1, Xinyi Liu2, Jia He1
1Department of Gastroenterology.
European journal of gastroenterology & hepatology
|September 3, 2025
まとめ
長期睡眠は,代謝関連脂肪肝 (MAFLD) の患者の心血管疾患 (CVD) のリスクを高めます. 最低のCVDリスクの最適な睡眠時間は,MAFLDと非MAFLD患者によって異なります.
科学分野:
- 心臓病科
- ヘパトロジー
- 睡眠医学
背景:
- メタボリック関連脂肪肝 (MAFLD) は,心血管疾患 (CVD) のリスクの増加と関連しています.
- MAFLD患者における睡眠期間とCVDリスクの関係はよくわかっていません.
研究 の 目的:
- MAFLD患者と無患者の睡眠期間とCVDリスクとの関連を調査する.
- これらの集団における心血管疾患のリスクを最小限に抑えるための潜在的な因果関係と最適な睡眠期間を探求する.
主な方法:
- 国家保健栄養調査 (2007-2020年) に参加した10386人のデータを分析した.
- 多変数ロジスティック回帰,サブグループ分析,限定立方スラインモデル,メンデルのランダム化 (MR) を利用した.
主要な成果:
- 長い睡眠時間 (≥9時間) は,MAFLD患者の心血管疾患のリスク増加と関連していた (OR=1. 92).
- 短い睡眠時間 (≤6時間) は,MAFLDでない個体においてより高いCVDリスクと関連していた (OR=1. 63).
- MAFLD患者では6. 7時間,非MAFLD患者では7. 9時間に最も低いCVDリスクが観察されました. MRは睡眠期間とCVDの間の因果関係を示唆した.
結論:
- 長時間の睡眠は,MAFLD患者の心血管疾患のリスクを高めます.
- 心血管の健康のために最適な睡眠時間は,MAFLDとMAFLDでない人によって異なります.
- 睡眠期間と心血管疾患のリスクとの間には因果関係がある.
関連する概念動画
Insufficient Sleep and Sleep Deprivation
210
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
210
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
Factors Affecting Drug Biotransformation: Biological
231
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
231
Substance Use Disorders Affecting Sleep
216
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
216
Sleep Apnea
220
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
220

